Literature DB >> 29395348

The Current Role of Bevacizumab in the Treatment of Hereditary Hemorrhagic Telangiectasia-Related Bleeding.

James R Gossage1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29395348     DOI： 10.1016/j.mayocp.2017.12.019

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  2 in total

1.  Patient-recorded benefit from nasal closure in a Danish cohort of patients with hereditary haemorrhagic telangiectasia.

Authors:  Jonas Hjelm Andersen; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-16       Impact factor: 2.503

2.  Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia.

Authors:  Stephanie Yung; Julie-Anne Bell; Jim Brooker
Journal:  J Hematol       Date:  2021-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.